Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer

Clinical trial NCT00126178 · TERMINATED

Trial details

NCT number: NCT00126178
Sponsor: Agenus Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Kidney Cancer Renal Cell Carcinoma

Start date: 2005-05-01
Primary completion: 2006-03-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.